血栓切除装置治疗急性肠系膜缺血的初步单中心经验
本文回顾性分析2011年1月至2016年1月单中心收治的20例急性肠系膜缺血患者,采用6F Rotarex减容装置经左肱动脉入路行血管内血运重建。技术成功定义为血管造影显示Riolan动脉弓再通,所有患者均成功完成,平均手术时间28±17分钟,30天死亡率为40%(n=8)。作者认为该技术可行且速度合理,但需进一步研究证实。
要点
- 20例急性肠系膜缺血患者经左肱动脉使用6F Rotarex装置行血栓切除术,均技术成功。
- 平均手术时间28±17分钟,30天死亡率为40%(n=8),无患者死于旋转血栓切除相关并发症。
- 作者认为早期诊断、外科与血管内专家紧密整合对加快治疗、减少广泛肠切除和死亡率至关重要。
核心结论
- 使用血栓切除装置对急性肠系膜缺血进行血管内治疗被证明技术可行且手术速度合理。
- 早期诊断和充分治疗仍是治疗的基石。
- 早期外科评估以及外科与血管内专家的紧密整合对于更快治疗、从而降低广泛外科切除和死亡率至关重要。
- 该领域需要进一步研究以证实这些发现。
研究设计与样本
- 回顾性分析2011年1月至2016年1月因急性肠系膜缺血入院并接受同期或单纯血管内治疗的患者。
- 共纳入20例患者,平均年龄69.8±11.3岁。
- 血管内治疗经左肱动脉入路,选择性插管并使用6F Rotarex减容装置(Straub Medical,Wangs,瑞士)行血栓切除。
- 技术成功定义为血管造影控制下Riolan动脉弓再通。
主要发现
- 入院时腹痛为最常见主诉(65%),其次为肠梗阻(35%)、脓毒症(25%),心肌梗死为主要临床转诊表现。
- 15例(75%)入院时CT有急性肠系膜缺血提示征象。
- 所有患者均经左肱动脉成功完成血管内血运重建,平均手术时间28±17分钟。
- 肠系膜上动脉为唯一受累血管者占75%,多数肠系膜上动脉闭塞位于 periosteal(30%)和结肠中动脉起源近端至中段(35%)。
- 所有患者均首选使用血栓切除装置,联合球囊血管成形术(7/20;50%)、支架置入(5/20;25%)、术中选择性溶栓(4/20;20%)和导管辅助抽吸(2/20;10%)。
临床怎么用
- 作者认为,使用血栓切除装置对急性肠系膜缺血进行血管内治疗技术可行且速度合理。
- 作者认为,早期诊断和充分治疗仍是治疗的基石。
- 作者认为,早期外科评估以及外科与血管内专家的紧密整合对于更快治疗、从而降低广泛外科切除和死亡率至关重要。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者指出该领域需要进一步研究以证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To report our preliminary experience with endovascular revascularization of patients with acute mesenteric ischemia (AMI), using thrombectomy devices. METHODS: It is a retrospective analysis of patients admitted to our hospital due to AMI and who were subjected to concomitant or exclusive endovascular treatment, from January 2011 to January 2016. Patients were admitted at the emergency department, underwent imaging investigation, and were referred to the endovascular specialist. Endovascular treatment was performed through left brachial artery access and selective catheterization and thrombectomy with a 6F Rotarex Debulking Device (Straub Medical, Wangs, Switzerland). Laparotomy was performed based on clinical and radiologic sings and at the discretion of the surgeon. Demographic, clinical/periprocedural, postoperative, complication, and adjunct intervention data were reviewed. Technical success was defined as recanalization of the Riolan's arcade on angiographic control. RESULTS: Twenty patients (mean age: 69.8 ± 11.3 years) underwent endovascular revascularization for AMI using thrombectomy devices, during the period of the study. Abdominal pain was the most common complain on admission (65%), with ileus (35%), sepsis (25%), and myocardial infarction as the main clinical referral presentation at admission. Fifteen patients (75%) had suggestive computer tomography (CT) signs of AMI on admission. Endovascular revascularization was successfully performed in all patients through the left brachial artery with a mean procedural time of 28 ± 17 min. Superior mesenteric artery (SMA) was the main vessel involved in 75% on a solely basis. The majority of the SMA occlusions were in the periosteal (30%) and proximal to middle colic artery offspring (35%). Primary use of thrombectomy devices was performed in all patients, associated with balloon angioplasty (7/20; 50%), stent deployment (5/20; 25%), intraoperative selective thrombolysis (4/20; 20%) and catheter-assisted aspiration in 10% (2/20) of patients. Average time between admission and computed tomography angiography was 1.5 ± 0.5 hr, between admission and angiographic procedure was 2.5 ± 1 hr, and between admission and surgery was 9 ± 5 hr. Following recanalization, 14 patients (70%) underwent open surgery. Laparotomy with intestinal resection (enterectomy, colectomy) and transit deviation was the most common procedure. Complications directly related to the endovascular procedure occurred in 2 patients, represented by self-limited small perforations. Overall 30-day mortality was 40% (n = 8). During the period of this study, no patient died as a result of complications related to the use of rotational thrombectomy. CONCLUSIONS: Endovascular treatment of the AMI with the use of thrombectomy devices proved to be technically feasible and reasonably fast procedure. Early diagnosis and adequate treatment remains the cornerstone of the treatment. Early surgical evaluation and close integration between surgical and endovascular specialists are crucial to faster treatment and consequently lower extensive surgical resections and mortality. Further studies are necessary on this field to confirm these findings.
引用
- Freitas B, Bausback Y, Schuster J, et al. Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience. Ann Vasc Surg. 2018. PMID: 29455017. doi:10.1016/j.avsg.2017.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。